Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London, EC4N 7BL, UK
Traxam 3.17% w/w Cutaneous Foam.
Felbinac 3.17% w/w Cutaneous Foam.
| Pharmaceutical Form |
|---|
|
Cutaneous foam (foam). This medicine is ‘quick-break’ foam dispensed from cans which contain a concentrate of 3.17% felbinac in ethanol/aqueous vehicle with butane propellant. |
Active Ingredient: Felbinac (Biphenylacetic Acid) 3.17% w/w.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Felbinac |
Felbinac is an active metabolite of fenbufen, belonging to the family of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used as a gel for local treatment of pain and inflammation associated with conditions of the musculo-skeletal system. |
| List of Excipients |
|---|
|
Ethanolamine USNF |
Aluminium monobloc can with white enamel body, double grinded microflex internal lacquer and colourless overlacquer. Cans are fitted with a valve made of aluminium microflex and diptube and shave foam actuator.
Pack sizes: 25g, 30g, (Pharmacy)
Pack sizes: 50g, 100g, (Prescription Only)
Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London, EC4N 7BL, UK
PL 12762/0086
09/04/1992 / 17/03/2003
| Drug | Countries | |
|---|---|---|
| TRAXAM | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
